PYRAZOLE-OXAZOLIDINONE COMPOUND FOR ANTI-HEPATITIS B VIRUS
申请人:Shanghai Zhimeng Biophama Co., Ltd.
公开号:US20190152963A1
公开(公告)日:2019-05-23
The present invention discloses a pyrazole-oxazolidinone compound having anti-hepatitis B virus activity, which has the structure of formula (I), wherein each variable is as defined herein.
[EN] THIAZOLIDINONES, OXAZOLIDINONES, AND PYRROLIDINONES FOR HBV<br/>[FR] THIAZOLIDINONES, OXAZOLIDINONES ET PYRROLIDINONES POUR LE VHB
申请人:VALEANT RES & DEV
公开号:WO2007014023A1
公开(公告)日:2007-02-01
[EN] The present invention relates to certain single-enantiomer pyrrazol-4-yl derivatives of thiazolidinones, oxazolidinones, and pyrrolidinones which are useful in the treatment of Hepatitis B virus. [FR] La présente invention se rapporte à certains pyrrazol-4-yls à énantiomère unique dérivés de thiazolidinones, d'oxazolidinones et de pyrrolidinones qui sont utiles dans le traitement du virus de l'hépatite B.